About ElectroCore
ElectroCore is a company based in Basking Ridge (United States) founded in 2005 by JP Errico.. ElectroCore has raised $161.39 million across 14 funding rounds from investors including Core Ventures Group, Merck Global Health Innovation Fund and American Investment Holdings. The company has 73 employees as of December 31, 2024. ElectroCore has completed 1 acquisition, including NeuroMetrix. ElectroCore offers products and services including gammaCore and gammaCore Sapphire. ElectroCore operates in a competitive market with competitors including Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others.
- Headquarter Basking Ridge, United States
- Employees 73 as on 31 Dec, 2024
- Founders JP Errico
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Electrocore, Inc.
-
Annual Revenue
$25.18 M57.09as on Dec 31, 2024
-
Net Profit
$-11.89 M36.89as on Dec 31, 2024
-
EBITDA
$-10.9 M37.85as on Dec 31, 2024
-
Total Equity Funding
$161.39 M (USD)
in 14 rounds
-
Latest Funding Round
$1.86 M (USD), Post-IPO
Oct 02, 2025
-
Investors
Core Ventures Group
& 4 more
-
Employee Count
73
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of ElectroCore
ElectroCore is a publicly listed company on the NASDAQ with ticker symbol ECOR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of ElectroCore
ElectroCore offers a comprehensive portfolio of products and services, including gammaCore and gammaCore Sapphire. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive stimulator for treating neurological disorders.
Advanced vagus nerve stimulator for specific health applications.
Unlock access to complete
Unlock access to complete
Funding Insights of ElectroCore
ElectroCore has successfully raised a total of $161.39M across 14 strategic funding rounds. The most recent funding activity was a Post-IPO round of $1.86 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 14
- Last Round Post-IPO — $1.9M
-
First Round
First Round
(15 Nov 2012)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Post-IPO - ElectroCore | Valuation |
investors |
|
| Jun, 2024 | Amount | Post-IPO - ElectroCore | Valuation |
investors |
|
| Aug, 2023 | Amount | Post-IPO - ElectroCore | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ElectroCore
ElectroCore has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Core Ventures Group, Merck Global Health Innovation Fund and American Investment Holdings. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech focused VC firm investing in seed stage startups in the US
|
Founded Year | Domain | Location | |
|
Corporate-backed venture capital is focused on the life science sector.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ElectroCore
ElectroCore has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include NeuroMetrix. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Wearable technology for pain, nerve disease and sleep disorders
|
1996 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - ElectroCore
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Electrocore Comparisons
Competitors of ElectroCore
ElectroCore operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Drugs for CNS disorders are developed and advanced.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Electrocore
Frequently Asked Questions about ElectroCore
When was ElectroCore founded?
ElectroCore was founded in 2005 and raised its 1st funding round 7 years after it was founded.
Where is ElectroCore located?
ElectroCore is headquartered in Basking Ridge, United States. It is registered at Basking Ridge, New Jersey, United States.
Who is the current CEO of ElectroCore?
Dan Goldberger is the current CEO of ElectroCore.
Is ElectroCore a funded company?
ElectroCore is a funded company, having raised a total of $161.39M across 14 funding rounds to date. The company's 1st funding round was a Post-IPO of $750K, raised on Nov 15, 2012.
How many employees does ElectroCore have?
As of Dec 31, 2024, the latest employee count at ElectroCore is 73.
What is the annual revenue of ElectroCore?
Annual revenue of ElectroCore is $25.18M as on Dec 31, 2024.
What does ElectroCore do?
ElectroCore was founded in 2005 and is headquartered in Basking Ridge, United States. Non-invasive vagus nerve stimulation devices, including the portable gammaCore, are developed by the company for medical applications. These devices deliver mild electrical signals to address migraines, cluster headaches, epilepsy, gastric motility disorders, depression, and anxiety. Operations focus on neuromodulation technology within the medical device sector.
Who are the top competitors of ElectroCore?
ElectroCore's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Biohaven Pharmaceutical.
What products or services does ElectroCore offer?
ElectroCore offers gammaCore and gammaCore Sapphire.
Is ElectroCore publicly traded?
Yes, ElectroCore is publicly traded on NASDAQ under the ticker symbol ECOR.
How many acquisitions has ElectroCore made?
ElectroCore has made 1 acquisition, including NeuroMetrix.
Who are ElectroCore's investors?
ElectroCore has 5 investors. Key investors include Core Ventures Group, Merck Global Health Innovation Fund, American Investment Holdings, Knoll Capital Management, and Easton Capital Investment Group.
What is ElectroCore's ticker symbol?
The ticker symbol of ElectroCore is ECOR on NASDAQ.